Identification of new biomarkers in the peripheral blood of patients with central nervous system injury

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000034666

Enrollment

Unknown

Registered

2020-07-14

Start date

2019-11-11

Completion date

Unknown

Last updated

2020-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

central nervous system injury

Interventions

Gold Standard:Clinical diagnosed

Index test:New&#32

biomarkers&#32

in&#32

peripheral&#32

blood

Eligibility

Sex/Gender

All

Age

25 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patient aged 25-90 years old; 2. The patient is suffering from stroke, brain injury, brain tumor and other central nervous system injuries; 3. The patient must be able to read, understand and complete the visual analog scale; 4. Patients voluntarily agree and sign the informed consent of clinical trial.

Exclusion criteria

Exclusion criteria: 1. Complicated with severe kidney, cardiovascular, liver and mental diseases; 2. Accompanied by serious medical diseases or infections (including but not limited to HBV or HIV carriers); 3. Pregnant or lactating women; 4. Those who cannot follow the test plan.

Design outcomes

Primary

Measure	Time frame
The amount of biomarkers;SEN, SPE, ACC, AUC of ROC;	—

Countries

China

Contacts

Public ContactXianting Ding

Institute for Personalized Medicine, Shanghai Jiao Tong University

dingxianting@sjtu.edu.cn+86 15601752012

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026